Efficacy and safety of Dentoxol® in the prevention of radiation-induced oral mucositis in head and neck cancer patients (ESDOM): a randomized, multicenter, double-blind, placebo-controlled, phase II trial
-
junio 2, 2022
![](https://davidrosenberg.cl/wp-content/uploads/2022/06/Screenshot_7.png)